title: [Immunoallergic transitory paraplegia after regional anaesthesia].
authors.forename: J
authors.initials: J
authors.lastname: Lahlou
authors.forename: M
authors.initials: M
authors.lastname: Bensghir
authors.forename: L
authors.initials: L
authors.lastname: Belyamani
authors.forename: T
authors.initials: T
authors.lastname: Boulahri
authors.forename: N
authors.initials: N
authors.lastname: Drissi Kamili
mesh_terms: D000328:Adult; D000775:Anesthesia, Spinal; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use; D002045:Bupivacaine / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D018856:Cystitis, Interstitial / Q000188:drug therapy; D004342:Drug Hypersensitivity / Q000188:drug therapy / Q000209:etiology*; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use; D009020:Morphine / Q000008:administration & dosage / Q000009:adverse effects* / Q000276:immunology; D010264:Paraplegia / Q000209:etiology* / Q000276:immunology; D011183:Postoperative Complications / Q000209:etiology* / Q000276:immunology; D011537:Pruritus / Q000139:chemically induced; D012074:Remission Induction; D012678:Sensation Disorders / Q000139:chemically induced
chemical_list: D000779:Anesthetics, Local; D000893:Anti-Inflammatory Agents; D009020:Morphine; D019274:Botulinum Toxins, Type A; D008775:Methylprednisolone; D002045:Bupivacaine